According to the European Commission, the amendment procedure for the EU Deforestation Regulation (EUDR) should only be a matter of postponement. However, the EPP Group is now also calling for substantive changes.
By Julia Dahm
Doubts about their suitability were raised during the hearings. However, Jessika Roswall and Hadja Lahbib have now been confirmed as Commissioners for the Environment and for Gender Equality respectively. Part of the compromise was the composition of the upgraded Health Committee.
By Alex Veit
Olivér Várhelyi was met with great reservations by MEPs at the hearing in the AGRI and ENVI Committees. However, the candidate for the Health and Animal Welfare portfolio was well prepared and did not allow himself to get carried away with emotional statements. Nevertheless, he was not nominated.
By Markus Grabitz
In its "AI Charter", GEMA formulates ethical guidelines for the use of artificial intelligence in the creative industries. With reference to the AI Act, the charter calls for transparency, fair treatment, and protection for creative services.
By Corinna Visser
The Committee on Economic and Monetary Affairs confirmed the Commissioner-designate for Financial Markets Maria Luís Albuquerque (EPP). During the hearing, the Portuguese Commissioner emphasized the importance of banking stability, a more integrated capital market, and a simpler framework for sustainable finance.
By
"Trump will try to weaken the EU institutions", writes Max Krahé in today's Opinion. To survive the foreseeable conflicts with the future US president, Europe must become more independent of the United States. The Weimar Triangle could play a central role in this.
By Experts Table.Briefings
At an event hosted by Table.Briefings and the German Marshall Fund at the North Rhine-Westphalia (NRW) State Representation, experts discussed the implications of the US election outcome. Political and business representatives agreed that the result would strain German-American relations.
By Maximilian Stascheit
Micropollutants enter the water through medicines or make-up. In the EU, manufacturers will have to bear a significant proportion of the treatment costs in the future. Pharmaceutical associations warn of more drug shortages.
By Lukas Knigge
